Director's Dealing • Jul 30, 2018
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 2140W
Drax Group PLC
30 July 2018
30 July 2018
Drax Group plc
("Drax" or "the Company")
Symbol: DRX
Notification of Transactions of Directors,
Persons Discharging Managerial Responsibility or Connected Persons
Andrew Koss has notified the Company that on 30 July 2018 he exercised his option over 5,633 ordinary shares in the Drax Group plc Sharesave Plan at an option price of £3.195 per share.
The total number of ordinary shares in which Andrew Koss has an interest following this acquisition is 57,746.
The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation 596/2014 notification and is in respect of ordinary shares of 11 16/29 pence each in the share capital of the Company of which there were 407,074,202 shares in issue at the time of the dealing.
Details of PDMR / person closely associated with them ("PCA")
Name
Andrew Koss
Reason for the notification
Position / status
Chief Executive, Drax Power
Initial notification / amendment
Initial Notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Drax Group plc
LEI
549300YPSNTXR4ZHSR98
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument
Identification code
Ordinary shares of 11 16/29 pence
GB00BIVNSX38
Nature of the transaction
Exercise of share options under the Drax Group plc sharesave plan
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £3.195 | 5,633 |
Aggregated information
- Aggregated volume
- Price
Date of the transaction
30/07/2018
Place of the transaction
Outside a trading venue
David McCallum
Company Secretary
--ENDS--
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHRMMATMBIJBIP
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.